Sumatriptan/naproxen sodium is a combination tablet containing sumatriptan 85 mg formulated with RT Technology (GlaxoSmithKline, North Carolina)
One study that evaluated the naproxen and
This combination product contains two ingredients: naproxen and sumatriptan
BACKGROUND:
The fixed-dose combination pill is often reserved as second-line treatment because of its cost, but using sumatriptan (50 mg) plus naproxen (500 mg) has been found noninferior
Recently issued FDA approval for marketing the combination (sumatriptan 50 mg–naproxen 500 mg) emphasizes the usefulness and safety of this new
Sumatriptan plus naproxen is now available in combination form for the acute treatment of migraine
Because the active metabolite of ozanimod inhibits MAO-B in vitro, there is a potential for serious adverse reactions, including hypertensive crisis
The FDA has approved the fixed-dose combination of sumatriptan and naproxen sodium as a treatment option for migraines in patients aged 12 or older
A migraine cocktail is a combination of medications that’s given in a medical setting to treat severe migraine symptoms
It works by constricting the dilated blood vessels in the brain, decreasing the release of chemical substances which stimulate pain, and blocking the pain signals in the brain
Sumatriptan and naproxen combination is used to treat acute migraine attacks
It can be used orally (pill), by nasal spray, or by injection (shot)
sleepiness or unusual drowsiness